|
業務類別
|
Biotechnology |
|
業務概覽
|
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases. |
| 公司地址
| 4930 Directors Place, Suite 500, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 858 500-8800 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.kuraoncology.com |
| 員工數量
| 260 |
| Dr. Mollie Leoni, M.D. |
Chief Medical Officer |
-- |
10/04/2026 |
| Dr. Francis Burrows, PhD |
Chief Scientific Officer |
-- |
10/04/2026 |
| Dr. Troy E. Wilson, PhD, J.D. |
Chairman of the Board, President and Chief Executive Officer |
美元 700.00K |
10/04/2026 |
| Ms. Kathleen Ford |
Chief Operating Officer |
美元 539.94K |
10/04/2026 |
| Ms. Teresa Brophy Bair, Esq. |
Chief Legal Officer and Secretary |
-- |
10/04/2026 |
| Mr. Brian T. Powl |
Chief Commercial Officer |
美元 506.35K |
10/04/2026 |
| Mr. Thomas Doyle |
Senior Vice President, Finance and Accounting and Principal Accounting Officer |
-- |
05/03/2026 |
|
|
| Ms. Carol A. Schafer |
Independent Director |
10/04/2026 |
| Mr. Faheem Hasnain |
Lead Independent Director |
10/04/2026 |
| Ms. Mary T. Szela |
Independent Director |
10/04/2026 |
| Mr. Thomas R. Malley |
Independent Director |
10/04/2026 |
| Dr. Michael J. Vasconcelles, M.D. |
Independent Director |
10/04/2026 |
| Dr. Troy E. Wilson, PhD, J.D. |
Chairman of the Board, President and Chief Executive Officer |
10/04/2026 |
| Dr. Helen Collins, M.D. |
Independent Director |
10/04/2026 |
| Ms. Diane L. Parks, M.B.A. |
Independent Director |
10/04/2026 |
|
|
|
|
